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revalence of Soft
laque Detection With
omputed Tomography*
atthew J. Budoff, MD, FACC
orrance, California
oronary calcium assessment is being increasingly used in
linical practice for risk stratification. Higher coronary
alcium scores are associated with increased plaque burden
nd increased cardiovascular risk. One concern is the pres-
nce of isolated lipid-laden (soft) plaque in the setting of a
egative study (zero calcium score). In this issue of the
ournal, Hausleiter et al. (1) suggest that the ability to detect
ipid-laden coronary plaques with cardiac computed tomog-
aphy (CT) angiography would possibly improve risk strat-
fication of these patients. The authors studied 161 consec-
tive patients with an intermediate risk for having coronary
rtery disease (CAD) and CT datasets were evaluated for
he presence of coronary calcifications, noncalcified plaques,
nd/or lumen narrowings. Coronary calcifications were
bsent in 63 of 161 (39%) patients, and the overall preva-
ence of patients with noncalcified plaques as the only
anifestation of CAD was 6.2% (10 of 161 patients). The
uthors surmise that with CT, “discernible noncalcified
therosclerotic coronary plaques can be detected in a large
roup of patients with an intermediate risk for having CAD.
he assessment of these plaques by CT angiography may
llow for improved cardiovascular risk stratification.” The
asic premise of the paper is that the detection of isolated
oft plaque adds significant information for the clinician.
hus, the question becomes: does noncalcific plaque detec-
ion improve on coronary calcium assessment?
See page 312
Several prospective studies have been conducted evaluat-
ng the negative predictive power of coronary artery calcifi-
ation (CAC) for obstructive disease. As a cost-effective
iagnostic test, noncalcific plaque detection would have to
dentify a significant number of patients with obstructive
isease in the absence of CAC. A large study, evaluating
onsecutive symptomatic persons undergoing cardiac cath-
terization, defined the frequency of noncalcific lesions
ausing obstruction. Knez et al. (2) studied 2,115 consecu-
ive symptomatic patients (n  1,404 men; mean age, 62 
*Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.
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eneral Electric.9 years) with no previous diagnosis of CAD, finding CAC
n more than 99% of patients with obstructive CAD. No
alcium was found in 7 of 872 men (0.7%) and in 1 of 383
omen (0.02%) who had significant luminal stenosis on
oronary angiography. Seven of these 8 patients were
ounger than 45 years of age. Assuming perfect sensitivity,
oncalcific plaque detection by CT would only have iden-
ified 8 additional patients of 1,255 (0.6%). Clearly, evalu-
ting patients with a probability of disease of only 0.6%
ould lead to many more false-positive than true-positive
esults, and the cost and risks could not be justified. Another
arge CAC and angiography study suggests the sensitivity of
AC for obstruction was 96% (3). Thus, 4% of symptom-
tic patients with obstructive disease were not detected by
se of CAC testing. Assuming noncalcific plaque detection
ith CT has a 78% sensitivity and 90% specificity (4), this
est will identify 3 cases per 100 to be true-positive and 9 to
e false-positive, for a positive predictive value of only 25%.
ubjecting patients to cardiac catheterization with such a
ow pretest probability and positive predictive value is not
arranted.
However, focusing this application where calcification
coring is less accurate (younger patients, patients with
moking history) may prove clinically useful. There are
everal studies demonstrating that CAC measurement has a
ower sensitivity in patients younger than 40 or 45 years of
ge (2,3). The most practical application of CT angiography
s improving on the limited specificity of CAC for obstruc-
ive disease. Because the presence of CAC often is associ-
ted with nonobstructive disease, specificity for obstructive
isease is reduced. The determination of significant stenotic
isease in persons with some level of calcification will
ndoubtedly be useful to the clinician and patient.
The use of contrast CT for risk stratification of the
symptomatic patient is problematic. The need for risk
tratification is the greatest for the person at intermediate
isk of cardiac events (5). Persons without coronary calcium
scores of zero) are at low risk of both obstructive disease
nd future cardiovascular events, so further risk stratification
s generally not warranted. Large prospective trials demon-
trate the risk of cardiac events in patients with patients
ithout coronary calcification (scores of zero) to be 0.1% per
ear. One recent study of 924 symptomatic patients under-
oing cardiac catheterization and CAC measurement dem-
nstrated no cardiac events over the next 3 years in patients
ith scores of zero, whereas 50 myocardial infarctions
ccurred in those with calcification. In asymptomatic pa-
ients, studies demonstrate that a positive test is associated
ith an approximate 10- to 12-fold increased risk of cardiac
vents (6,7). In one large prospective, population-based
tudy, 4,903 asymptomatic persons ages 50 to 70 years
nderwent electron beam CT scanning of the coronary
rteries. At 4.3 years, 119 patients had sustained at least one
ardiovascular event. For coronary calcium score threshold
100 versus 100, relative risk was 9.6 for all cardiovas-
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Editorial Comment July 18, 2006:319–21ular events, 11.1 for all CAD events, and 9.2 for nonfatal
yocardial infarction and death. The coronary calcium
core predicted CAD events independently of standard risk
actors and C-reactive protein (p  0.004) and was superior
o the Framingham risk index in the prediction of events
area under the receiver-operating characteristic curve of
.79  0.03 vs. 0.69  0.03, p  0.0006). More impor-
antly, only 8 of 1,504 (0.5%) persons with scores of zero
ad a coronary event during the next 4.3 years, and the
nnual event rate was only 0.1%, which makes patients
ithout coronary calcification very low risk, diminishing the
eed for further risk stratification with such tests as cardiac
T angiography. Isolated lipid-laden plaque is only one
otential cause of cardiac events in this population. These
atients could have suffered events from a nonatheroscle-
otic cause (thrombus, spasm, embolism), had nondetect-
ble plaque present (the sensitivity of lipid-laden plaque by
T compared with intravascular ultrasound is only 78%)
4), or had another risk for CAD (inflammation, advanced
ipid abnormalities, endothelial dysfunction, or one of the
yriad of new cardiovascular risk factors being suggested).
o significantly change management, CT angiography
ould have to increase a person’s risk by 20-fold to rise from
.1% per year to 2.0% per year (low risk to high risk for
ardiovascular events). A younger asymptomatic population
oses an even greater challenge to improve upon coronary
alcium risk stratification with CT angiography. Taylor et al.
7) prospectively followed 3,000 persons (mean age, 43 years)
or 3 years. The CHD events occurred in only 2 of 1,263
articipants without CAC (event rate 0.16%; p  0.0001).
hus, a negative scan was associated with a 0.05% per year risk.
n this cohort, findings on CT angiography would have to
fford a 40-fold risk to move patients to the high-risk category.
The identification of a noncalcified plaque may very well
e a plaque at an earlier stage of atherosclerosis, more
menable to antiatherosclerotic therapies. Identifying a
erson with a large area of lipid-laden plaque and then
nitiating lipid-lowering therapy to treat the asymptomatic
AD has logical appeal. However, one question is whether
T angiography can properly differentiate different types of
oncalcific atherosclerotic plaque. Fibrous plaque generally
s considered more stable (less vulnerable), whereas soft
laques with a large lipid core are far more vulnerable to
upture. Several CT studies have demonstrated that the
ipid-rich plaque has a lower, but overlapping attenuation
attern to fibrous-rich plaque (4). The mean CT density
alues for lipid-laden plaques are usually around 30 to 50
ounsfield units (HU) whereas the attenuation of a more
brous lesion is around 90 HU. Although there is no issue
bout detecting noncalcific plaque from the blood pool or
alcium, there is substantial overlap between lipid-laden and
brous plaque, not always permitting consistent differenti-
tion (4). Before clinical use of CT angiography for soft
laque detection, further studies are needed to demonstrate
nter-reader and interscan reproducibility of the measure,
utopsy studies are needed to validate quantification anddentification of plaque burden, and validation of CT
odalities ability is needed to separate coronary plaque
omposition into lipid- or fibrous-rich plaques.
For the asymptomatic person, it appears that coronary
alcium detection is better suited to identify the vulnerable
atient (that person who is at significantly increased risk of
uture cardiovascular events). The measurement of CAC
equires no contrast, minimal radiation exposure, and takes
nly minutes to perform. A vulnerable plaque is defined by
thin fibrous cap (measured in microns, below the resolu-
ion of CT), associated with inflammatory cells and a
ipid-laden core. Whether CT angiography can accurately
epict the lipid-laden core needs more research. The au-
hors (1) correctly conclude that “the risk for ischemic
vents in patients with noncalcified plaques as well as the
dditive value of noncalcified plaque detection over tradi-
ional calcium scoring are currently not known.” The
ccuracy in the evaluation of soft plaque is improving with
echnological advancements with CT, and we are coming
loser to defining the vulnerable plaque in a noninvasive
anner. It would not be surprising to find that current
nformation from CT angiography significantly influences
ardiac morbidity or mortality. We may also come to rely on
his modality to monitor plaque stabilization and potential
egression in patients receiving antiatherosclerotic therapy.
The use of CT angiography is currently well suited for the
ymptomatic patient, potentially identifying those patients
ho need revascularization and/or advanced medical ther-
py. The use of CT angiography remains a robust method
o evaluate coronary stenosis and will assist clinicians in
valuating congenital heart disease, coronary anomalies,
re-electrophysiology procedures, diagnosis of obstructive
AD in the symptomatic person and evaluation postrevas-
ularization. The implications of isolated noncalcific plaque
re currently unknown, and making assumptions about
ulnerability may be premature. Current data strongly
uggests a person with a negative calcium score is at very low
isk for cardiovascular events and obstructive disease (8).
he use of CT angiography in this setting to try to modify
isk will require significant research before clinical use.
eprint requests and correspondence: Dr. Matthew J. Budoff,
os Angeles Biomedical Research Center at Harbor-UCLA, 1124
est Carson Street, RB2, Torrance, California 90502. E-mail:
budoff@labiomed.org.
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